Resources
AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals
AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals Deals mark an important...
Read MoreWe must fix the business model for new antibiotics
AMR Action Fund CEO Henry Skinner and BIO CEO Dr. Michelle McMurry-Heath co-authored a Fortune op-ed on policy solutions to the...
Pressure grows for market reforms to help tackle ‘silent pandemic’ of AMR
The Financial Times reported on the challenges of bringing new antibiotics to market and the growing political will to remedy the...
More Investment Sorely Needed to Combat Antimicrobial Resistance
MedPage today reported on the struggles that some biotechs face as they develop antibiotics. The article featured news from the...
Antibiotic resistance in the patient with cancer
The current focus on the coronavirus disease 2019 (COVID-19) pandemic means a lack of attention to other health challenges, such as antimicrobial resis- tance.
Drug-resistant Infections Led to $1.9 Billion in Health Care Costs
Superbugs that are resistant to existing antibiotics already take an enormous toll on health-care systems around the world.
A research and development fund for new treatments for bacteria...
The current focus on the coronavirus disease 2019 (COVID-19) pandemic means a lack of attention to other health challenges, such as antimicrobial resis- tance.
It's time to fix the antibiotic market...
We need to keep developing new antibiotics to make sure we can keep protecting ourselves from ever-evolving bacteria
Biopharmaceutical Representative Joins New Antibiotic Resistanc...
Superbugs that are resistant to existing antibiotics already take an enormous toll on health-care systems around the world.
Joint Statement On World Antimicrobial Awareness Week...
The International Society for Quality in Health Care (ISQua), the International Hospital Federation (IHF), the International Alliance of Patients’ Organizations (IAPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) support the Tripartite Organizations.
